SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+5.68%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$177M
AUM Growth
+$177M
(+5.7%)
Cap. Flow
+$6.13M
Cap. Flow
% of AUM
3.45%
Top 10 Holdings %
Top 10 Hldgs %
81.28%
Holding
26
New
3
Increased
10
Reduced
6
Closed
5
Top Buys
| 1 |
VIVE
VIVEVE MED INC
VIVE
|
$7.88M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$4.48M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$4.13M |
| 4 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
$4.06M |
| 5 |
Vericel Corp
VCEL
|
$3.87M |
Top Sells
| 1 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
$3.85M |
| 2 |
Veracyte
VCYT
|
$3.6M |
| 3 |
ALR
Alere Inc
ALR
|
$3.38M |
| 4 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$2.86M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$2.17M |
Sector Composition
| 1 | Healthcare | 92.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCTL
1
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $25.1M | 14.16% |
2,874,317
| – | – |
|
|
VIVE
2
DELISTED
VIVEVE MED INC
VIVE
| $24.3M | 13.67% |
3,849,711
+1,250,000
| +48% | +$7.88M |
|
|
NVLN
3
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $16.8M | 9.44% |
1,560,487
+36,453
| +2% | +$392K |
|
|
SCLN
4
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $16.3M | 9.19% |
1,663,281
+414,081
| +33% | +$4.06M |
|
|
ISEE
5
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $12.9M | 7.25% |
3,516,489
+1,223,589
| +53% | +$4.48M |
|
|
ALR
6
DELISTED
Alere Inc
ALR
| $10.9M | 6.16% |
275,000
-85,000
| -24% | -$3.38M |
|
|
7
Vericel Corp
VCEL
$1.75B
| $9.14M | 5.15% |
3,265,323
+1,381,523
| +73% | +$3.87M |
|
|
CORV
8
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $8.3M | 4.68% |
2,757,260
-401,556
| -13% | -$1.21M |
|
|
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.4B
| $7.28M | 4.1% |
752,410
+426,323
| +131% | +$4.13M |
|
10
Enanta Pharmaceuticals
ENTA
$193M
| $5.7M | 3.21% |
185,099
-46,814
| -20% | -$1.44M |
|
|
BDSI
11
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $5.41M | 3.05% |
2,844,820
+244,109
| +9% | +$464K |
|
|
12
Veracyte
VCYT
$2.38B
| $5.31M | 2.99% |
578,200
-392,300
| -40% | -$3.6M |
|
13
Cumberland Pharmaceuticals
CPIX
$53.9M
| $5.14M | 2.89% |
739,917
+120,379
| +19% | +$835K |
|
|
ALIM
14
DELISTED
Alimera Sciences, Inc.
ALIM
| $3.61M | 2.03% |
2,576,273
-2,039,540
| -44% | -$2.86M |
|
15
DURECT Corp
DRRX
$60.2M
| $2.94M | 1.66% |
2,801,376
+623,585
| +29% | +$655K |
|
|
TRIB
16
Trinity Biotech
TRIB
$5.25M
| $2.1M | 1.18% |
351,917
-84,149
| -19% | -$501K |
|
17
Emergent Biosolutions
EBS
$439M
| $1.58M | 0.89% |
+54,505
| New | +$1.58M |
|
18
Xoma
XOMA
$415M
| $625K | 0.35% |
+87,960
| New | +$625K |
|
19
Vanda Pharmaceuticals
VNDA
$277M
| $606K | 0.34% |
+43,300
| New | +$606K |
|
|
VXRT
20
DELISTED
Vaxart
VXRT
| $205K | 0.12% |
314,421
+5,143
| +2% | +$3.35K |
|
|
CUTR
21
DELISTED
Cutera, Inc.
CUTR
| – | – |
-120,429
| Closed | -$2.09M |
|
|
MNK
22
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-43,629
| Closed | -$2.17M |
|
|
JNP
23
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| – | – |
-228,392
| Closed | -$1.28M |
|
|
SCMP
24
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| – | – |
-284,002
| Closed | -$3.85M |
|
|
CTIC
25
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| – | – |
-2,617,136
| Closed | -$1.07M |
|